Trial Profile
Infectious Complications in Liver Transplant Patients treated with Vedolizumab for Inflammatory Bowel Disease: An retrospective analysis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Nov 2019
Price :
$35
*
At a glance
- Drugs Vedolizumab (Primary)
- Indications Crohn's disease; Ulcerative colitis
- Focus Therapeutic Use
- 18 Jan 2018 New trial record